This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Macrogenics, Inc.. Active years: 2014-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2021
Title: Robyn Gerena: Innovator in Antibody Therapeutics
Introduction
Robyn Gerena is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of antibody therapeutics, holding a total of 3 patents. His work focuses on developing innovative solutions for various medical conditions, particularly in the realm of cancer treatment.
Latest Patents
One of Robyn Gerena's latest patents is centered around FcγRIIB-specific antibodies and methods of use thereof. This invention relates to antibodies or fragments that specifically bind to FcγRIIB, particularly human FcγRIIB, with greater affinity than those that bind to FcγRIIA. The patent outlines the use of an anti-FcγRIIB antibody or an antigen-binding fragment as a single-agent therapy for treating, preventing, managing, or ameliorating cancers such as B-cell chronic lymphocytic leukemia or non-Hodgkin's lymphoma. Additionally, it addresses autoimmune disorders, inflammatory disorders, and IgE-mediated allergic disorders. The invention also provides methods to enhance the therapeutic effect of existing antibodies and improve the efficacy of vaccine compositions.
Career Highlights
Robyn Gerena is currently employed at Macrogenics, Inc., where he continues to advance his research in antibody therapeutics. His innovative work has positioned him as a key figure in the development of new treatments for serious health conditions.
Collaborations
Robyn collaborates with talented individuals in his field, including Leslie Sydnor Johnson and Ling Ling Huang. Their combined expertise contributes to the success of their projects and the advancement of therapeutic innovations.
Conclusion
Robyn Gerena's contributions to the field of antibody therapeutics demonstrate his commitment to improving medical treatments. His innovative patents and collaborations highlight the importance of research in developing effective therapies for complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile